These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17875748)

  • 41. Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase.
    Stagno F; Vigneri P; Del Fabro V; Stella S; Massimino M; Berretta S; Messina A; Di Raimondo F
    Leuk Res; 2009 Jun; 33(6):e17. PubMed ID: 19036439
    [No Abstract]   [Full Text] [Related]  

  • 42. A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment.
    Janssen JJ; Berendse HW; Schuurhuis GJ; Merle PA; Ossenkoppele GJ
    Am J Hematol; 2009 Oct; 84(10):679-82. PubMed ID: 19658186
    [No Abstract]   [Full Text] [Related]  

  • 43. Imatinib mesilate for the treatment of gastrointestinal stromal tumour.
    Cassier PA; Dufresne A; Arifi S; El Sayadi H; Labidi I; Ray-Coquard I; Tabone S; Méeus P; Ranchère D; Sunyach MP; Decouvelaere AV; Alberti L; Blay JY
    Expert Opin Pharmacother; 2008 May; 9(7):1211-22. PubMed ID: 18422477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regression of cutaneous squamous cell carcinoma in a patient with chronic myeloid leukaemia on imatinib mesylate treatment.
    Kawakami Y; Nakamura K; Nishibu A; Yanagihori H; Kimura H; Yamamoto T
    Acta Derm Venereol; 2008; 88(2):185-6. PubMed ID: 18311459
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug maker's vow to donate cancer medicine falls short.
    Strom S; Fleischer-Black M
    N Y Times Web; 2003 Jun; ():A1, C7. PubMed ID: 14621708
    [No Abstract]   [Full Text] [Related]  

  • 46. [Current progress in therapy of malignant diseases].
    Hiddemann W; Heinemann V
    Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1837-40. PubMed ID: 16052450
    [No Abstract]   [Full Text] [Related]  

  • 47. Initial experience with the human tumor stem cell assay system: potential and problems.
    Von Hoff DD; Harris GJ; Johnson G; Glaubiger D
    Prog Clin Biol Res; 1980; 48():113-24. PubMed ID: 7208514
    [No Abstract]   [Full Text] [Related]  

  • 48. Targeted therapies: the answer to individualized treatment?
    Hutchinson L
    Nat Clin Pract Oncol; 2007 Jun; 4(6):323. PubMed ID: 17534387
    [No Abstract]   [Full Text] [Related]  

  • 49. Anticancer drugs.
    Reese DM
    Nature; 1995 Dec; 378(6557):532. PubMed ID: 8524372
    [No Abstract]   [Full Text] [Related]  

  • 50. Fluoxydin. (Preliminary report on clinical evaluation).
    Kolár V; Mechl Z
    Neoplasma; 1971; 18(5):485-7. PubMed ID: 5119523
    [No Abstract]   [Full Text] [Related]  

  • 51. Phase II evaluation of AT-1727 in advanced human cancer.
    Zhang ZY; Liu TF; Zhang XF
    Chin Med J (Engl); 1983 Aug; 96(8):601-3. PubMed ID: 6416759
    [No Abstract]   [Full Text] [Related]  

  • 52. In vitro drug assay: pharmacologic considerations.
    Alberts DS; Chen HS; Salmon SE
    Prog Clin Biol Res; 1980; 48():197-207. PubMed ID: 7193870
    [No Abstract]   [Full Text] [Related]  

  • 53. [Peroral fluoropyrimidines in chemotherapy for malignant tumors].
    Semiglazova TIu; Gershanovich ML
    Vopr Onkol; 2001; 47(4):388-95. PubMed ID: 11710276
    [No Abstract]   [Full Text] [Related]  

  • 54. This time it's personal.
    Gravitz L
    Sci Am; 2014 Jul; 311(1):S6-8. PubMed ID: 24974699
    [No Abstract]   [Full Text] [Related]  

  • 55. Resisting resistance.
    Ewan S
    Drug Discov Today; 2005 Aug; 10(15):1015. PubMed ID: 16055015
    [No Abstract]   [Full Text] [Related]  

  • 56. [Current pharmacotherapy of neoplastic diseases. II].
    Witkowska M
    Wiad Lek; 1969 Jul; 22(14):1307-13. PubMed ID: 5344011
    [No Abstract]   [Full Text] [Related]  

  • 57. Response.
    Yener U; Avsar T; Akgün E; Şeker A; Bayri Y; Kılıç T
    J Neurosurg; 2013 Nov; 119(5):1353. PubMed ID: 24344455
    [No Abstract]   [Full Text] [Related]  

  • 58. Angiogenesis.
    Huang LC; Hsu KH; Hueng DY
    J Neurosurg; 2013 Nov; 119(5):1352. PubMed ID: 23991840
    [No Abstract]   [Full Text] [Related]  

  • 59. A progression puzzle.
    Bernards R; Weinberg RA
    Nature; 2002 Aug; 418(6900):823. PubMed ID: 12192390
    [No Abstract]   [Full Text] [Related]  

  • 60. Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity.
    Koehler M; Donnelly ET; Kalanovic D; Dagher R; Rothenberg ML
    Ann Oncol; 2016 Jul; 27(7):1342-8. PubMed ID: 27029709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.